Do you have diabetes, high blood pressure, high cholesterol, or heart failure?
If you are interested in learning more about your health and medications, you may be eligible to participate in a research study! A LECOM Pharmacist is conducting a study looking at the effect of having clinical pharmacists perform medication management education for chronic diseases. You may qualify if you are over 18 years old and have at least one of the following chronic diseases: hypertension, dyslipidemia, diabetes, and heart failure.
You must be willing to meet with a pharmacist or nurse face to face at least three times over a period of 12 months at your doctor’s office and participate in monthly follow-up visits or phone calls. And you must be willing to provide a small blood sample three times during the study.
You may receive at no cost:
- Study-related care
- Medication therapy management sessions with a pharmacist
- Information about your health and medications
- And compensation for your time
Patients may be placed into one of two groups. The first is the “usual care group” where you will see your primary care provider as usual, and have no contact with the clinical pharmacist in the study. You may be placed in the “pharmacist-intervention group”. In this study, the pharmacist-intervention group will receive medication therapy management services monthly in addition to the usual care provided by your primary care provider.
If you agree to participate in this study, you will meet with the clinical nurse and/or the pharmacist face-to-face at least three times over a 12 month period from January 2018 to December 2018. These three visits will take place in January, June/July, and December. At the first session, you will be asked to complete a brief form providing demographic information (ie. gender, race, age) and medical and prescription history information. The form will be similar to medical forms that you have completed at your doctor’s office. The researcher will also ask you a brief questionnaire about your attitudes about prescription medications. A nurse will also obtain a blood sample to check your blood glucose and/or blood cholesterol levels. There is no cost to you for any blood samples obtained at this visit. If you have had relevant labs obtained by your physician in the previous 30 days, samples will not need to be obtained at this visit. It is estimated that the first session will last 60 minutes. If you are in the pharmacist-intervention group, you will also meet with a pharmacist at this session to review your medications.
After the initial visit, you may need to attend monthly follow-up sessions or participate in phone calls so that the researcher may observe any changes in your medical or prescription history, or answer any questions about your medicines. During some of the follow-up sessions, you may also have to answer questions about your health over the past month. A nurse may obtain a blood sample to look for changes in your laboratory values at sessions 6 and 12. There is no cost to you for any blood samples obtained at these visits. If you have had relevant labs obtained by your physician in the previous 30 days, samples will not need to be obtained at these visits. It is estimated that the follow-up sessions or phone calls will take no more than 30 minutes. There will be no charge to you for any study-related visits with the nurse or pharmacist.
As a result of your participation in the study, a pharmacist may communicate with your primary care physician regarding your medications. Your physician may then order changes to your medication regimen, changes in medication dosing, additions of medications to your regimen, removal of medications from your regimen, changes to your medication costs, or changes regarding physician referral and needs for follow-up care. You will be responsible for any costs associated with the above changes. There are no direct costs associated with each of the 12 pharmacist or nursing visits, or any blood tests collected during study visits.
For more information, contact the Medication Therapy Management Study team at (814) 860-5131 or firstname.lastname@example.org.